)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
AlzeCure Pharma
AlzeCure Pharma (ALZCUR) investor relations material
AlzeCure Pharma Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary26 Feb, 2026
Executive summary
Focused on advancing clinical programs in Alzheimer's and pain, with key grants and regulatory milestones achieved.
Received EUR 2.5 million EIC grant for Phase II trial of NeuroRestore ACD856 in Alzheimer's; first disbursement in December.
Orphan Drug Designation granted for pain candidate ACD440 by both FDA and EMA, supporting rare disease development.
Completed oversubscribed rights issue, raising SEK 58.5 million before expenses, strengthening financial position.
Continued business development and out-licensing discussions for pipeline assets.
Financial highlights
Net sales were SEK 0 thousand for both Q4 and full year 2025, unchanged from prior year.
Q4 2025 net loss was SEK -17,742 thousand, compared to SEK -9,354 thousand in Q4 2024.
Full year 2025 net loss was SEK -47,654 thousand, versus SEK -35,348 thousand in 2024.
Cash and cash equivalents at year-end were SEK 50,336 thousand, up from SEK 31,498 thousand.
Research expenses accounted for 75.7% of operating expenses in 2025.
Outlook and guidance
Main focus for 2026 is preparation and execution of Phase II clinical study with NeuroRestore ACD856.
Preparing TrkA-NAM ACD137 (osteoarthritis pain) and Alzstatin ACD680 (Alzheimer's) for Phase I trials.
Ongoing business development to secure out-licensing or partnership agreements.
Evaluating additional funding opportunities, including potential EIC direct investment.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AlzeCure Pharma earnings date
Q1 20265 May, 2026
AlzeCure Pharma
Next AlzeCure Pharma earnings date
Q1 20265 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
AlzeCure Pharma AB is a Swedish pharmaceutical company focused on developing treatments for severe diseases related to the central nervous system, particularly Alzheimer's disease. The company operates primarily through two research platforms: NeuroRestore, aimed at restoring cognitive functions by stimulating essential brain signaling pathways, and Alzstatin, which targets reducing the production of amyloid beta, a key factor in Alzheimer's pathology. AlzeCure's drug pipeline includes ACD856, a candidate for treating Alzheimer's, depression, and traumatic brain injuries, currently in phase I clinical trials, as well as several other preclinical candidates for pain and neurodegenerative conditions. AlzeCure is headquartered in Stockholn, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage